Effect of probucol in hyperlipidemic patients during two years of administration
- 1 August 1978
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 96 (2), 213-217
- https://doi.org/10.1016/0002-8703(78)90088-1
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Drug Therapy of HyperlipoproteinemiaPublished by American Medical Association (AMA) ,1976
- Sensitization to epinephrine-induced ventricular fibrillation produced by probucol in dogsToxicology and Applied Pharmacology, 1973
- The additive effects of clofibrate and probucol (DH-581) on rat serum cholesterolAtherosclerosis, 1973
- Toxicity of [4,4′-(isopropylidenedithio)bis(2,6-di-t-butylphenol)], probucol, in mice, rats, dogs and monkeys: Demonstration of a species-specific phenomenonToxicology and Applied Pharmacology, 1973
- Mode of action of a new hypocholesteraemic drug (DH-581) in familial hypercholesteraemiaAtherosclerosis, 1972
- Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and DisordersNew England Journal of Medicine, 1967
- Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and DisordersNew England Journal of Medicine, 1967
- Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and DisordersNew England Journal of Medicine, 1967
- Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and DisordersNew England Journal of Medicine, 1967
- A semiautomated procedure for the determination of triglycerides in serumAnalytical Biochemistry, 1964